A Changing Landscape: How Pandemic Response Affects Antimicrobial Resistance

October 12-13, 2021
8:30-10:30 ET

Virtual Conference

Join FHI 360 for a two-day virtual symposium with global experts in infectious diseases and global health security to discuss the emerging consequences of the intersection between the COVID-19 pandemic and antimicrobial resistance (AMR).

 

AMR is a global public health threat with a substantial human and economic impact. It occurs when bacteria, fungi and parasites stop responding to and become resistant to antimicrobial medications. The scale of AMR has increased rapidly in recent years, especially in countries where regulations that control antibiotic prescription and use in humans and animals are weak or nonexistent.

 

The COVID-19 pandemic may have long-term consequences on the continued global emergence and acceleration of AMR, and researchers are exploring how antibiotic use changed during this time. Countries and health systems need to act now to address this public health threat.

 

This symposium, hosted by FHI 360's Emerging Infectious Diseases and Health Security Division, will provide thought leadership on how increased and inappropriate use of antibiotics during a pandemic can lead to undesirable consequences.

 

Sessions will address these topics:

  • Antibiotic use and misuse during the pandemic: Implications for the future of AMR
  • The role and importance of laboratory diagnostics in mitigating the impact of AMR
  • The importance of integrating AMR stewardship measures into country-level pandemic response
  • One Health: Zoonoses implications for AMR

Agenda

TuesdayOctober 12, 2021

8:30am ET
Opening Plenary
Welcome
Janet Robinson, FIBS, Director, Emerging Infectious Diseases and Health Security, FHI 360

 

Keynote Address
Lord Jim O’Neill, Economist and Chairman, Council of Chatham House, the Royal Institute of International Affairs
8:50am ET
Panel Discussion and Q&A
Moderator
Pat Sadate-Ngatchou, PhD, Technical Director, Emerging Infectious Diseases and Health Security, FHI 360

 

Panelists
Bradley Langford, BscPhm, ACPR, PharmD, BCPS, Pharmacist Consultant, Antimicrobial Stewardship Program, Public Health Ontario
Thuy Doan, MD, PhD, Associate Professor, Proctor Foundation, University of California at San Francisco
Sabiha Essack, BPharm, MPharm, PhD, South African Research Chair in Antibiotic Resistance and One Health and Professor in Pharmaceutical Sciences, University of KwaZulu-Natal
Isidore Bonkoungou, PhD, Assistant Professor in Microbiology, University Joseph KI-ZERBO (University of Ouagadougou)
9:30am ET
Breakout Session #1
Lessons learned from antibiotic use and misuse during the COVID-19 pandemic
Moderator and rapporteur: Bradley Langford

 

Role and importance of laboratory diagnostics in mitigating the impact of AMR
Moderator and rapporteur: Thuy Doan

 

The importance of integrating AMR stewardship measures into the pandemic response in countries
Moderator and rapporteur: Sabiha Essack

 

One Health: Zoonoses implications for AMR
Moderator and rapporteur: Isidore Bonkoungou
10:00am ET
Closing Remarks for Day 1
Janet Robinson

WednesdayOctober 13, 2021

8:30am ET
Opening Plenary
Welcome
Janet Robinson
8:35am ET
Breakout Session #2
Summary Reports from Breakout Session #1 and Presentation of Solution Framework

 

Lessons learned from antibiotic use and misuse during the COVID-19 pandemic
Bradley Langford

 

Role and importance of laboratory diagnostics in mitigating the impact of AMR
Thuy Doan

 

The importance of integrating AMR stewardship measures into the pandemic response in countries
Sabiha Essack

 

One Health: Zoonoses implications for AMR
Isidore Bonkoungou
10:00am ET
Closing Plenary
Summary, Lessons Learned, Blog Launch and Closing Remarks
Janet Robinson

Media Inquiries

For any questions about the event or how we can help, reach out to our FHI 360 media contact.
Allison Bozniak
Associate Director, Corporate and Regional Communications
Lead photo credit: Jessica Scranton/FHI 360